Comparison of outcomes in augmentation naïve and augmented patients with alpha-1 antitrypsin deficiency related lung disease.
P. Ellis (Birmingham, United Kingdom), K. Holm (Denver, United States of America), R. Choate (Lexington, United States of America), D. Mannino (Lexington, United States of America), R. Stockley (Birmingham, United Kingdom), R. Sandhaus (Denver, United States of America), A. Turner (Birmingham, United Kingdom)
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Ellis (Birmingham, United Kingdom), K. Holm (Denver, United States of America), R. Choate (Lexington, United States of America), D. Mannino (Lexington, United States of America), R. Stockley (Birmingham, United Kingdom), R. Sandhaus (Denver, United States of America), A. Turner (Birmingham, United Kingdom). Comparison of outcomes in augmentation naïve and augmented patients with alpha-1 antitrypsin deficiency related lung disease.. 3383
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: